本页面由Tiger Trade Technology Pte. Ltd.提供服务

SpyGlass Pharma Inc

26.40
+10.4065.00%
盘后25.63-0.7700-2.92%18:40 EST
成交量:119.48万
成交额:3,112.29万
市值:8.42亿
市盈率:- -
高:32.44
开:24.00
低:20.16
收:16.00
52周最高:32.44
52周最低:20.16
股本:3,191.12万
流通股本:940.00万
量比:- -
换手率:12.71%
股息:- -
股息率:- -
净资产收益率:--
总资产收益率:--
市净率:--
市盈率(LYR):- -

数据加载中...

公司资料

公司名字:
SpyGlass Pharma Inc
交易所:
NASDAQ
成立时间:
2019
员工人数:
32
公司地址:
27061 Aliso Creek Road,Suite 100,Aliso Viejo,California,United States
邮编:
92656
传真:
- -
简介:
SpyGlass Pharma, Inc.根据特拉华州法律于2019年1月7日注册成立。该公司是一家处于后期阶段的生物制药公司,正在启动其先导产品的3期临床试验,这是一种IOL挂载、控释、药物递送系统,旨在通过药物比马前列素的递送来治疗青光眼。其使命是通过开发持久的药物递送解决方案来显著改善患有慢性眼病的患者的生活,这些解决方案可以让患者和外科医生对长期疾病控制和视力保护充满信心。

董事

名称
职位
Patrick Mooney
Chief Executive Officer and Director
Ali Behbahani
Independent Director
Bilal Khan
Independent Director
Elizabeth O Farrell
Independent Director
Geoff Pardo
Independent Director
Habib J. Dable
Independent Director
Kirk Nielsen
Independent Director
Malik Y. Kahook
Chief Medical Officer and Director and Executive Chair of the Board and President
Michael Dybbs
Independent Director
Zach Scheiner
Independent Director

股东

名称
职位
Patrick Mooney
Chief Executive Officer and Director
James Dennewill
Chief Operating Officer
Jean Frederic Viret
Chief Financial Officer
Chetan Pujara
Chief Research and Development Officer
Malik Y. Kahook
Chief Medical Officer and Director and Executive Chair of the Board and President